Also trades as: SOM.AX (ASX) · $vol 0M
SOMNF OTC
SomnoMed Limited
1W: +0.0%
1M: -46.7%
3M: -46.7%
YTD: -52.9%
1Y: -45.5%
3Y: -45.5%
5Y: -86.0%
$0.24
-0.00 (-0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$8M
+6.2% ▲
5Y CAGR: +25.0%
Capital Expenditures
$3M
-34.5% ▼
5Y CAGR: -4.7%
Free Cash Flow
$5M
-6.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$745K
-33.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$8M | -$12M | -$3M | -$3M |
| Depreciation & Amort. | $4M | $5M | $7M | $6M | $5M |
| Stock-Based Comp. | $1M | $1M | $77K | $2M | $0 |
| Change in Working Capital | $2M | -$3M | -$3M | -$4M | $263K |
| Other Non-Cash Items | $7M | $14M | $2M | $8M | $5M |
| Operating Cash Flow | $2M | -$4M | -$6M | $8M | $8M |
| — Investing Activities — | |||||
| Capital Expenditures | -$9M | -$6M | -$1M | -$2M | -$6M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $317K | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$4M | -$2M | $0 |
| Investing Cash Flow | -$8M | -$6M | -$5M | -$4M | -$6M |
| — Financing Activities — | |||||
| Net Debt Issuance | $2M | $7M | -$17M | -$3M | -$3M |
| Stock Repurchased | $0 | $0 | -$2M | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $15K | $0 | -$3M | -$44K | $2M |
| Financing Cash Flow | $2M | $7M | $17M | -$3M | -$1M |
| Net Change in Cash | -$5M | -$4M | $4M | $1M | $745K |
| Cash End of Period | $16M | $12M | $16M | $17M | $17M |
| Free Cash Flow | -$7M | -$10M | -$8M | $5M | $5M |